Paulsen Gisela 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Paulsen Gisela
Former President and COO
Transactions
- Award
Common Stock, no par value
2022-08-15+175,000→ 191,500 total - Award
Common Stock, no par value
2022-08-15+350,000→ 541,500 total
Footnotes (2)
- [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date.
- [F2]The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.